Cargando…
Gut Microbiota and the Paradox of Cancer Immunotherapy
It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985000/ https://www.ncbi.nlm.nih.gov/pubmed/24778636 http://dx.doi.org/10.3389/fimmu.2014.00157 |
_version_ | 1782311516879454208 |
---|---|
author | Poutahidis, Theofilos Kleinewietfeld, Markus Erdman, Susan E. |
author_facet | Poutahidis, Theofilos Kleinewietfeld, Markus Erdman, Susan E. |
author_sort | Poutahidis, Theofilos |
collection | PubMed |
description | It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression while sustaining whole body good health. Stimulated by a gut microbiota-centric systemic homeostasis hypothesis, we set out to explore the influence of the gut microbiome to explain the paradoxical roles of regulatory T-lymphocytes in cancer development and growth. This paradigm shift places cancer prevention and treatment into a new broader context of holobiont engineering to cultivate a tumor-suppressive macroenvironment. |
format | Online Article Text |
id | pubmed-3985000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39850002014-04-28 Gut Microbiota and the Paradox of Cancer Immunotherapy Poutahidis, Theofilos Kleinewietfeld, Markus Erdman, Susan E. Front Immunol Immunology It is recently shown that beneficial environmental microbes stimulate integrated immune and neuroendocrine factors throughout the body, consequently modulating regulatory T-lymphocyte phenotypes, maintaining systemic immune balance, and determining the fate of preneoplastic lesions toward regression while sustaining whole body good health. Stimulated by a gut microbiota-centric systemic homeostasis hypothesis, we set out to explore the influence of the gut microbiome to explain the paradoxical roles of regulatory T-lymphocytes in cancer development and growth. This paradigm shift places cancer prevention and treatment into a new broader context of holobiont engineering to cultivate a tumor-suppressive macroenvironment. Frontiers Media S.A. 2014-04-07 /pmc/articles/PMC3985000/ /pubmed/24778636 http://dx.doi.org/10.3389/fimmu.2014.00157 Text en Copyright © 2014 Poutahidis, Kleinewietfeld and Erdman. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Poutahidis, Theofilos Kleinewietfeld, Markus Erdman, Susan E. Gut Microbiota and the Paradox of Cancer Immunotherapy |
title | Gut Microbiota and the Paradox of Cancer Immunotherapy |
title_full | Gut Microbiota and the Paradox of Cancer Immunotherapy |
title_fullStr | Gut Microbiota and the Paradox of Cancer Immunotherapy |
title_full_unstemmed | Gut Microbiota and the Paradox of Cancer Immunotherapy |
title_short | Gut Microbiota and the Paradox of Cancer Immunotherapy |
title_sort | gut microbiota and the paradox of cancer immunotherapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985000/ https://www.ncbi.nlm.nih.gov/pubmed/24778636 http://dx.doi.org/10.3389/fimmu.2014.00157 |
work_keys_str_mv | AT poutahidistheofilos gutmicrobiotaandtheparadoxofcancerimmunotherapy AT kleinewietfeldmarkus gutmicrobiotaandtheparadoxofcancerimmunotherapy AT erdmansusane gutmicrobiotaandtheparadoxofcancerimmunotherapy |